The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis
- 2 May 2005
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 23 (24), 3187-3195
- https://doi.org/10.1016/j.vaccine.2004.12.021
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Multicenter Study of a Rapid Molecular-Based Assay for the Diagnosis of Group B Streptococcus Colonization in Pregnant WomenClinical Infectious Diseases, 2004
- Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide–Protein Conjugate VaccinesThe Journal of Infectious Diseases, 2004
- Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccineVaccine, 2003
- Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate VaccinesInfection and Immunity, 2001
- Use of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccine for Type II Group BStreptococcusin Healthy WomenThe Journal of Infectious Diseases, 2000
- Safety and Immunogenicity of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and IbThe Journal of Infectious Diseases, 1999
- Neonatal Group B Streptococcal Infection in a Managed Care PopulationObstetrics & Gynecology, 1998
- The Pediatric Costs of Strategies for Minimizing the Risk of Early-Onset Group B Streptococcal DiseaseObstetrics & Gynecology, 1997
- The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at deliveryObstetrics & Gynecology, 1996
- Strategies for the Prevention of Early-Onset Neonatal Group B Streptococcal SepsisObstetrics & Gynecology, 1994